Patel, Jay
Rassekh, Negin
Fonarow, Gregg C.
Deedwania, Prakash
Sheikh, Farooq H.
Ahmed, Ali
Lam, Phillip H.
Article History
Accepted: 1 May 2023
First Online: 31 May 2023
Declarations
:
: Ali Ahmed was supported in part by research grants from the National Institutes of Health (1RF1AG069121, 1R01HL156518, and 1R01AG073474) and the Department of Veterans Affairs (I01HX002422 and 1I01HX003552).
: Gregg C. Fonarow reports consulting with Abbott, Amgen, Astra Zeneca, Bayer, Cytokinetics, Edwards, Eli Lilly, Janssen, Medtronic, Merck, Novartis, and Pfizer. Farooq H. Sheikh reports institutional research support from Abbott, Alnylam, and Ionis, and has received speaker’s fees from Abbott for an educational conference. Jay Patel, Negin Rassekh, Prakash Deedwania, Ali Ahmed, and Phillip H. Lam report no conflicts of interest in relation to this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of their respective institutions.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the writing of this manuscript.